January 24, 2019 News Horizon Discovery has introduced a new CRISPR screening service for use on primary human T cells, which will be valuable in researching biological processes and developing new drugs. You Might Also Like Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression May 11, 2022 We have moved! December 2, 2020 Unchained Labs has the inside track on Lentivirus RNA detection, launches new Leprechaun application! January 17, 2024
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression May 11, 2022
Unchained Labs has the inside track on Lentivirus RNA detection, launches new Leprechaun application! January 17, 2024